We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform for cancer treatment capable of autonomously evolving solutions to any tumour scenario.
Each partner in EVO-NANO has their own specific competencies and experience. The combination of our expertise and overlap of knowledge will make us achieve our objectives of create novel new cancer therapies.
This project has received funding from the European Union's Horizon 2020 FET Open programme under grant agreement. No. 800983.